| Cardiovascular Risk Management |
1 |
1 |
| Gastroesophageal Reflux Disease |
0 |
0.98 |
| Proton Pump Inhibitor |
0 |
0.99 |
| Acute Coronary Syndrome |
0 |
0.32 |
| Healthcare and Medical Technology |
0 |
0.3 |
| Angina Pectoris |
0 |
0.26 |
| Cerebrovascular Accident |
0 |
0.15 |
| Myocardial Infarction (MI) |
0 |
0.15 |
| Meta-Analysis |
0 |
0.14 |
| Artificial Intelligence |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Histamine |
0 |
0.07 |
| Infarction |
0 |
0.07 |
| Maryland |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Unstable Angina |
0 |
0.07 |